Skip to content
Learning that drives better investment decisions

Johnson & Johnson – World Class Benchmarking

By Become a Better Investor | Apr 25, 2024

Johnson & Johnson (JNJ US): Profitable Growth rank of 1 was up compared to the prior period’s 2nd rank. This is World Class performance compared to 380 large Health Care companies worldwide.

Read More

Sinovac Biotech – World Class Benchmarking

By Become a Better Investor | Apr 24, 2024

Sinovac Biotech Limited (SVA US): Profitable Growth rank of 8 was same compared to the prior period’s 8th rank. This is below average performance compared to 400 medium Health Care companies worldwide.

Read More

Pfizer – World Class Benchmarking

By Become a Better Investor | Apr 23, 2024

Pfizer Incorporated (PFE US): Profitable Growth rank of 5 was down compared to the prior period’s 1st rank. This is average performance compared to 380 large Health Care companies worldwide.

Read More

AstraZeneca – World Class Benchmarking

By Become a Better Investor | Apr 22, 2024

AstraZeneca PLC (AZN LN): Profitable Growth rank of 4 was down compared to the prior period’s 3rd rank. This is above average performance compared to 380 large Health Care companies worldwide.

Read More

Become a Better Investor Newsletter – 20 April 2024

By Andrew Stotz | Apr 20, 2024

The bond trade hasn’t played out. S&P 500 is down in terms of gold. Manager allocates 70% of its AUM to cash. Bitcoin is 3x-levered NASDAQ. Fast food outpaces inflation.

Read More

Goal Setting Is Often An Act of Desperation: Part 2

By Andrew Stotz | Apr 19, 2024

Do you struggle to meet your goals or targets? Find out how you can change your thinking about goals and your process for setting them so you can keep moving forward. In this episode, John Dues and host Andrew Stotz discuss the first five of John’s 10 Key Lessons for Data Analysis.

Read More

Sinopharm Group – World Class Benchmarking

By Become a Better Investor | Apr 18, 2024

Sinopharm Group Company Limited (1099 HK): Profitable Growth rank of 8 was same compared to the prior period’s 8th rank. This is below average performance compared to 380 large Health Care companies worldwide.

Read More

Prada SpA – World Class Benchmarking

By Become a Better Investor | Apr 17, 2024

Prada SpA (1913 HK): Profitable Growth rank of 2 was up compared to the prior period’s 4th rank. This is World Class performance compared to 880 large Cons. Disc. companies worldwide.

Read More

Burberry Group – World Class Benchmarking

By Become a Better Investor | Apr 16, 2024

Burberry Group PLC (BRBY LN): Profitable Growth rank of 2 was same compared to the prior period’s 2nd rank. This is World Class performance compared to 880 large Cons. Disc. companies worldwide.

Read More

Kering SA – World Class Benchmarking

By Become a Better Investor | Apr 15, 2024

Kering SA (KER FP): Profitable Growth rank of 3 was down compared to the prior period’s 2nd rank. This is above average performance compared to 880 large Cons. Disc. companies worldwide.

Read More